Equities

Net Medical Xpress Solutions Inc

NMXS:PKC

Net Medical Xpress Solutions Inc

Actions
  • Price (USD)0.0121
  • Today's Change-0.004 / -24.14%
  • Shares traded1.14k
  • 1 Year change--
  • Beta-0.6580
Data delayed at least 15 minutes, as of Jul 05 2024 14:30 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Net Medical Xpress Solutions, Inc. is a provider of solutions for the telemedicine industry. The Company recruits and maintains a cadre of telemedicine physicians, which it provides to the industry, together with its own software that links electronic medical records while facilitating state-of-the-art conferencing and communications. The Company also offer a call center, hardware implementations, staffing and recruiting operations, diagnostic and clinical services, and advanced software research and development capabilities. All of these product and service offerings are in support of, and integrated with, its physician services revenues. In addition to its core system, which it uses to build a customized telemedicine management system for clients. It has engineered and developed various hardware products, which it offers to the Company’s customers. It also offers medical laboratory services.

  • Revenue in USD (TTM)2.67m
  • Net income in USD-303.00k
  • Incorporated2005
  • Employees19.00
  • Location
    Net Medical Xpress Solutions Inc8206 Louisiana Blvd., Suite AALBUQUERQUE 87113United StatesUSA
  • Phone+1 (505) 255-1999
  • Fax+1 (505) 255-7201
  • Websitehttps://www.welcome.netmedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tekumo Inc209.99k11.08m386.35k32.000.0006--0.0381.840.74130.74130.0158-0.23930.1019----6,562.19546.51------4.92--5,363.22--0.0671------80.44--8.51------
Missfresh Ltd (ADR)379.93m-207.88m391.68k57.00------0.001-27.20-27.2096.14-27.201.5229.1755.016,665,373.00-83.83------21.02---55.18--0.0978-6.00-----60.28--63.75------
Riskon International Inc304.71k-59.00m394.88k16.00------1.30-41.40-49.830.107-0.74540.0091--0.491119,044.38-188.36-87.35-391.00-226.27-624.356.39-20,717.24-598.79---------100.00---8,714.23---32.07--
Maptelligent Inc0.00447.99k396.31k------0.8637---0.0022-0.00220.00-0.00160.00------93.90-1,235.89-----------162,348.80---0.3483---------97.60------
Strake Inc195.29k-3.67m404.08k--------2.07-19.71-19.721.06-3.401.45--2.86---2,730.55------29.49---1,877.22-----14.69--------80.75------
Creatd Inc2.92m-56.72m404.09k14.00------0.1383-493.64-493.6419.22-78.570.50326.3522.72208,739.30-583.76-464.86-----7.72---1,160.17-1,081.970.0116-29.06----11.55118.803.17--111.65--
Innovaro Inc527.69k-6.08m416.11k7.00------0.7886-0.3795-0.30140.0328-0.04510.0555--3.5675,384.29-64.02-46.37-181.47-54.0010.1835.79-1,152.93-163.25---1.211.11--21.91-51.75-11.93---1.31--
Global Arena Holding Inc749.61k-1.62m443.96k682.00------0.5923-0.001-0.0010.0002-0.01121.30-------280.5148.96---------215.9942.93---0.7316-----43.015.53-88.01------
Net Medical Xpress Solutions Inc2.67m-303.00k455.78k19.00--1.23--0.1705-0.0156-0.01560.13760.00983.0299.2511.53---34.26-11.69-90.58-35.9625.7723.53-11.33-3.111.02-21.300.2586---27.88-1.03-327.81------
Startech Labs Inc0.00-66.68k460.92k-----------0.0011-0.00110.00-0.0060.00-------16,670.00-1,440,820.00---------------1.25---------2.68------
Mobile Global Esports Inc4.96k-6.58m488.44k16.00--0.1925--98.48-0.3059-0.30590.00020.11950.0009----310.00-112.24---120.44--100.00---132,770.00------0.0103-------426.28------
Qian Yuan Baixing Inc12.89m-574.76k526.02k15.00------0.0408-0.0326-0.03260.7198-0.12984.9716.258.11859,464.00-20.99------11.13---4.22--0.338-1.3712.22--10.02--41.09------
Greater Cannabis Company Inc0.00-189.94k549.48k1.00---------0.0003-0.00030.00-0.00090.00----0.00-96.36-351.47-------67.99---5,532.78---11.58--------47.71------
Il2m International Corp0.00-4.68m549.53k2.00---------0.0353-0.03530.00-0.00690.00-------9,516.51-----------------3.10-----100.00---15,452.06------
Data as of Jul 05 2024. Currency figures normalised to Net Medical Xpress Solutions Inc's reporting currency: US Dollar USD

Institutional shareholders

0.07%Per cent of shares held by top holders
HolderShares% Held
Connectus Wealth LLCas of 31 Mar 202427.22k0.07%
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.